University of Arizona College of Public Health
Drachman Hall, Room A116
1295 N. Martin Ave.
Tucson, Arizona 85719
AND
University of Arizona College of Medicine – Phoenix
Building 2, Room 2306
600 E. Van Buren St.
Phoenix, AZ 85004
Presented by the UA James E. Rogers College of Law and UA Health Sciences:
TOPIC: “Total Artificial Heart: How Do You Get Lifesaving Treatments Paid For?”
SPEAKER: Marvin J. Slepian, MD | Professor of Medicine (Division of Cardiology, Department of Medicine, UA College of Medicine – Tucson), Medical Imaging, Materials Science & Engineering and Biomedical Engineering; Member, UA Sarver Heart Center and UA BIO5 Institute; Associate Department Head for Biomedical Engineering Clinical and Industrial Affairs, UA College of Engineering; McGuire Scholar, UA Eller College of Management; Director, Arizona Center for Accelerated Biomedical Innovation, University of Arizona; and Adjunct Professor, Biomedical Engineering, Stony Brook University, Stony Brook, N.Y., and Oral Biology, University of Medicine and Dentistry of New Jersey (UMDNJ)/Rutgers Biomedical and Health Sciences, Newark, N.J.
WHEN: Tuesday, Feb. 19, 2019
12:05-12:55 p.m.
Q&A: 1-1:30 p.m.
Lunch will be served. Please RSVP by email to Mackenzie Pish at pishm@email.arizona.edu
WHERE:
Tucson campus (in person): Drachman Hall, Room A116, 1295 N. Martin Ave.
Phoenix campus (by video): Building 2, Room 2306, 600 E. Van Buren St.
Locations connect via videoconference. Regulatory Science Series webcast through UAHS BioCommunications: https://streaming.biocom.arizona.edu
More about the Speaker
Marvin J. Slepian, MD, is a Professor of Medicine and the Associate Department Head of Clinical/Industrial Affairs at the University of Arizona. He is a prolific inventor with more than 55 issued and filed patents and has been the founder of numerous medical device companies including SynCardia Systems, Inc., the maker of the CardioWest Temporary Total Artificial Heart (TAH-t) Polymer Chemistry, Assisted Devices. The CardioWest™ TAH-t completely replaces the blood-pumping function of the diseased heart. For patients with end-stage congestive heart failure at imminent risk of death, this device has proven to be a life-saver, allowing them to be "bridged" and supported until a human heart transplant can be performed. Learn more...
The Regulatory Science Series is sponsored jointly by the University of Arizona Health Sciences and the James E. Rogers College of Law. Tucson and Phoenix attendees connect by videoconference. For more information, visit https://law.arizona.edu/regulatory-science